In colorectal cancer, overexpression of the Src protein and epigenetic changes in the tumor cell have been correlated with increased activity of Src kinase [3, 8], which clinically has been associated with shorter disease-free survival in patients undergoing curative resection and with shorter overall survival in patients with metastatic disease [9]. The gene discussed is SRC; the disease is neoplasm.